动态对比增强灌注面积探测器CT与FDG PET/CT在非小细胞肺癌N分期诊断效能中的初步比较
本研究纳入77例非小细胞肺癌患者,直接比较动态首过对比增强灌注面积探测器CT与FDG PET/CT在鉴别转移性与非转移性淋巴结及评估N分期方面的能力。结果显示,系统性动脉灌注(Az=0.89)、渗透表面(Az=0.78)和SUVmax(Az=0.85)的ROC曲线下面积显著大于总灌注(Az=0.70)和分布容积(Az=0.55)。结论认为动态首过CE灌注ADCT在鉴别转移性与非转移性淋巴结及评估N分期方面与FDG PET/CT同样有用。
要点
- 系统性动脉灌注(Az=0.89)与SUVmax(Az=0.85)对淋巴结转移的诊断效能相近,均优于总灌注和分布容积。
- 系统性动脉灌注在双输入最大斜率模型下与病理N分期的一致性为实质性(κ=0.70),SUVmax为中等(κ=0.60)。
- 动态首过CE灌注ADCT在NSCLC的N分期评估中与FDG PET/CT同样有用。
核心结论
- 动态首过CE灌注ADCT在鉴别转移性与非转移性淋巴结及评估NSCLC患者N分期方面与FDG PET/CT同样有用。
研究设计与样本
- 连续纳入77例非小细胞肺癌患者(男45例,平均年龄70.4±5.9岁;女32例,平均年龄71.2±7.7岁),行动态首过CE灌注ADCT(两个或三个不同位置覆盖全胸)、FDG PET/CT、手术治疗及病理检查;以病理诊断为参考标准,基于每个淋巴结的ROI测量灌注参数和SUVmax,行ROC曲线分析及卡方和kappa统计比较N分期。
诊断标准与关键数值
- 系统性动脉灌注Az=0.89、渗透表面Az=0.78、SUVmax Az=0.85,三者ROC曲线下面积均显著大于总灌注(Az=0.70,p<0.05)和分布容积(Az=0.55,p<0.05);系统性动脉灌注(双输入最大斜率模型)与病理N分期一致性κ=0.70(p<0.0001),SUVmax一致性κ=0.60(p<0.0001)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The objective of our study was to directly compare the capability of dynamic first-pass contrast-enhanced (CE) perfusion area-detector CT (ADCT) and FDG PET/CT for differentiation of metastatic from nonmetastatic lymph nodes and assessment of N stage in patients with non-small cell lung carcinoma (NSCLC).
SUBJECTS AND METHODS: Seventy-seven consecutive patients, 45 men (mean age ± SD, 70.4 ± 5.9 years) and 32 women (71.2 ± 7.7 years), underwent dynamic first-pass CE-perfusion ADCT at two or three different positions for covering the entire thorax, FDG PET/CT, surgical treatment, and pathologic examination. From all ADCT data for each of the subjects, a whole-chest perfusion map was computationally generated using the dual- and single-input maximum slope and Patlak plot methods. For quantitative N stage assessment, perfusion parameters and the maximum standardized uptake value (SUVmax) for each lymph node were determined by measuring the relevant ROI. ROC curve analyses were performed for comparing the diagnostic capability of each of the methods on a per-node basis. N stages evaluated by each of the indexes were then statistically compared with the final pathologic diagnosis by means of chi-square and kappa statistics.
RESULTS: The area under the ROC curve (Az) values of systemic arterial perfusion (Az = 0.89), permeability surface (Az = 0.78), and SUVmax (Az = 0.85) were significantly larger than the Az values of total perfusion (Az = 0.70, p < 0.05) and distribution volume (Az = 0.55, p < 0.05). For each of the threshold values, agreement for systemic arterial perfusion calculated using the dual-input maximum slope model was substantial (κ = 0.70, p < 0.0001), and agreement for SUVmax was moderate (κ = 0.60, p < 0.0001).
CONCLUSION: Dynamic first-pass CE-perfusion ADCT is as useful as FDG PET/CT for the differentiation of metastatic from nonmetastatic lymph nodes and assessment of N stage in patients with NSCLC.
引用
- Ohno Y, Fujisawa Y, Sugihara N, et al. Dynamic Contrast-Enhanced Perfusion Area-Detector CT: Preliminary Comparison of Diagnostic Performance for N Stage Assessment With FDG PET/CT in Non-Small Cell Lung Cancer. AJR Am J Roentgenol. 2017. PMID: 28929810. doi:10.2214/AJR.17.17959
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。